Evestia Clinical – the new brand identity for EMAS Pharma – launches today as a market leading pharmaceutical research specialist focussed on Clinical Trials in Oncology and Rare Diseases

Posted on by

LETCHWORTH GARDEN CITY, England, March 20, 2025 /PRNewswire/ — Evestia Clinical has today been announced as the new identity of EMAS Pharma, as it sets its sights on rapid growth as a provider of clinical research in oncology and rare diseases globally. Evestia Clinical is backed by…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.